ARDSLEY, N.Y. -
July 22, 2022 -
PRLog -- The uveitis treatment market is expected to witness a CAGR of around 6% during the forecast period. Uveitis is a form of eye inflammation that affects the middle layer of tissue in the eye wall (uvea). Possible causes of uveitis are infection, injury, an autoimmune or inflammatory disease, eye redness or pain, light sensitivity, blurred vision, floating spots in the patient's field of vision, and decreased vision are some main factors for uveitis, and it can be serious, leading to permanent vision loss to the patient. Early diagnosis and treatment are important to prevent complications. Furthermore, the treatment provided by doctors is surgical procedures or some general medications according to the disease such as corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, and drugs are the major factors for the growth of the uveitis treatment market. For instance, according to an article published by the Ocular Immunology and Uveitis Foundation in April 2022, uveitis afflicts 109,000 people in the U.S. and 43,000 new cases are diagnosed.
According to UnivDatos Market Insights (UMI)
' research report
"Uveitis Treatment Market", is expected to witness a CAGR growth of around 6% during the forecast period 2021-2027F. This can be mainly attributed to an increase in government funding coupled with the development of novel drugs and treatments.
For more informative information, please visit us –
https://univdatos.com/report/uveitis-treatment-market/
Account Phone Number